Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

NCT00408915 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Continuous Subcutaneous Lisuride Infusion

Sponsor

Axxonis Pharma AG